2024 |
04/26 | 665 | 676 | 663 | 674 | +0.75% | 55,800 | 178億4474万 | -3.44% |
04/25 | 670 | 675 | 664 | 669 | -1.04% | 60,900 | 177億1236万 | -4.56% |
04/24 | 680 | 680 | 668 | 676 | 0% | 71,100 | 178億9769万 | -3.98% |
04/23 | 681 | 681 | 671 | 676 | +0.45% | 28,500 | 178億9769万 | -4.38% |
04/22 | 667 | 673 | 663 | 673 | +2.75% | 36,700 | 178億1826万 | -5.08% |
04/19 | 663 | 667 | 652 | 655 | -2.24% | 62,200 | 173億4170万 | -7.75% |
04/18 | 658 | 672 | 657 | 670 | +1.82% | 35,100 | 177億3883万 | -6.03% |
04/17 | 668 | 669 | 657 | 658 | -1.35% | 54,100 | 174億2112万 | -7.84% |
04/16 | 676 | 676 | 663 | 667 | -1.91% | 106,600 | 176億5941万 | -6.97% |
04/15 | 672 | 684 | 670 | 680 | 0% | 46,200 | 180億359万 | -5.29% |
04/12 | 704 | 708 | 666 | 680 | -3% | 235,300 | 180億359万 | -5.42% |
04/11 | 700 | 705 | 698 | 701 | -0.14% | 45,000 | 185億5959万 | -2.77% |
04/10 | 700 | 707 | 698 | 702 | -0.57% | 44,000 | 185億8606万 | -2.5% |
04/09 | 702 | 708 | 700 | 706 | +0.57% | 37,000 | 186億9197万 | -1.81% |
04/08 | 713 | 715 | 702 | 702 | -0.28% | 43,200 | 185億8606万 | -2.36% |
04/05 | 700 | 708 | 698 | 704 | -0.71% | 61,100 | 186億3901万 | -2.09% |
04/04 | 714 | 715 | 706 | 709 | -0.42% | 35,800 | 187億7139万 | -1.53% |
04/03 | 718 | 723 | 710 | 712 | -1.66% | 44,600 | 188億5082万 | -1.25% |
04/02 | 736 | 736 | 723 | 724 | -1.09% | 62,400 | 191億6853万 | +0.42% |
04/01 | 736 | 736 | 721 | 732 | -0.41% | 35,900 | 193億8034万 | +1.53% |
03/29 | 732 | 741 | 732 | 735 | +1.52% | 45,900 | 194億5977万 | +1.94% |
03/28 | 725 | 735 | 720 | 724 | -2.03% | 46,700 | 191億6853万 | +0.56% |
03/27 | 735 | 746 | 735 | 739 | +0.54% | 59,000 | 195億6567万 | +2.78% |
03/26 | 740 | 743 | 729 | 735 | -1.08% | 58,400 | 194億5977万 | +2.37% |
03/25 | 750 | 755 | 743 | 743 | -1.59% | 62,400 | 196億7157万 | +3.63% |
03/22 | (IR情報)15:00 執行役員人事に関するお知らせ |
03/22 | (IR情報)15:00 取締役、監査役人事に関するお知らせ |
03/22 | 746 | 756 | 742 | 755 | +1.34% | 28,900 | 199億8928万 | +5.89% |
03/21 | 770 | 783 | 745 | 745 | -1.19% | 192,500 | 197億2453万 | +4.78% |
03/19 | (IR情報)10:00 人工股関節新製品Trivicta Hip Stemの米国食品医薬品局(FDA)薬事承認取得、及び米国販売に関するお知らせ |
03/19 | 720 | 755 | 715 | 754 | +4.72% | 148,400 | 199億6281万 | +6.2% |
03/18 | 712 | 720 | 710 | 720 | +1.69% | 44,600 | 190億6263万 | +1.55% |
03/15 | 715 | 715 | 708 | 708 | -0.84% | 74,400 | 187億4492万 | 0% |
03/14 | 711 | 714 | 706 | 714 | +0.42% | 42,600 | 189億377万 | +0.71% |
03/13 | 719 | 719 | 706 | 711 | -0.7% | 38,600 | 188億2435万 | 0% |
03/12 | 703 | 716 | 692 | 716 | +1.27% | 62,800 | 189億5673万 | +0.42% |
03/11 | 706 | 713 | 697 | 707 | -0.28% | 88,600 | 187億1844万 | -1.12% |
03/08 | 707 | 712 | 690 | 709 | -0.28% | 116,900 | 187億7139万 | -0.98% |
03/07 | (IR情報)13:00 中国製造「Balanced Knee System」の薬事承認取得、及び中国市場での販売開始に関するお知らせ |
03/07 | 692 | 746 | 679 | 711 | +4.1% | 554,800 | 188億2435万 | -0.84% |
03/06 | 686 | 693 | 678 | 683 | -0.87% | 66,200 | 180億8302万 | -5.01% |
03/05 | 693 | 694 | 682 | 689 | -0.86% | 53,500 | 182億4188万 | -4.57% |
03/04 | 706 | 710 | 693 | 695 | -1.84% | 96,100 | 184億73万 | -4.27% |
03/01 | 724 | 726 | 701 | 708 | -1.94% | 114,900 | 187億4492万 | -2.88% |
02/29 | 731 | 733 | 720 | 722 | -0.96% | 48,600 | 191億1558万 | -1.23% |
02/28 | 718 | 734 | 718 | 729 | +0.97% | 50,100 | 193億91万 | -0.68% |
02/27 | 725 | 733 | 719 | 722 | -0.41% | 43,900 | 191億1558万 | -1.9% |
02/26 | 722 | 733 | 713 | 725 | +1.12% | 84,200 | 191億9501万 | -1.63% |
02/22 | 710 | 723 | 710 | 717 | +1.41% | 62,300 | 189億8320万 | -2.85% |
02/21 | 707 | 720 | 701 | 707 | +0.71% | 79,400 | 187億1844万 | -4.46% |
02/20 | 716 | 717 | 702 | 702 | -2.5% | 127,000 | 185億8606万 | -5.39% |
02/19 | 704 | 720 | 699 | 720 | +1.98% | 109,900 | 190億6263万 | -3.23% |
02/16 | (IR情報)13:00 人工膝関節新製品「Balanced Knee System Uni」の日本国内販売に関するお知らせ |
02/16 | 667 | 708 | 667 | 706 | +6.65% | 215,000 | 186億9197万 | -5.36% |
02/15 | 690 | 690 | 654 | 662 | -4.89% | 261,400 | 175億2703万 | -11.5% |
02/14 | 703 | 704 | 691 | 696 | -2.52% | 111,000 | 184億2721万 | -7.57% |
02/13 | 723 | 723 | 704 | 714 | -1.11% | 75,400 | 189億377万 | -5.56% |
02/09 | 713 | 733 | 711 | 722 | +1.26% | 88,100 | 191億1558万 | -4.62% |
02/08 | 726 | 732 | 702 | 713 | -2.06% | 181,000 | 188億7730万 | -6.18% |
02/07 | 762 | 762 | 724 | 728 | -4.96% | 172,800 | 192億7444万 | -4.34% |
02/06 | 771 | 791 | 765 | 766 | 0% | 112,400 | 202億8052万 | +0.39% |
02/05 | 755 | 771 | 747 | 766 | +2.54% | 98,100 | 202億8052万 | +0.52% |
02/02 | 731 | 753 | 731 | 747 | +2.33% | 83,000 | 197億7748万 | -1.84% |
02/01 | 759 | 767 | 728 | 730 | -2.67% | 119,100 | 193億2739万 | -4.07% |
01/31 | (IR情報)15:00 2024年3月期第3四半期決算短信〔日本基準〕(連結) |
01/31 | 756 | 756 | 739 | 750 | -1.32% | 120,500 | 198億5691万 | -1.57% |
01/30 | 770 | 772 | 755 | 760 | -0.78% | 79,600 | 201億2166万 | -0.13% |
01/29 | 770 | 771 | 764 | 766 | -0.52% | 52,700 | 202億8052万 | +0.66% |
01/26 | 774 | 781 | 762 | 770 | -1.03% | 72,400 | 203億8642万 | +1.32% |
01/25 | 767 | 790 | 766 | 778 | +1.3% | 67,400 | 205億9823万 | +2.5% |
01/24 | 778 | 781 | 766 | 768 | -1.41% | 47,400 | 203億3347万 | +1.45% |
01/23 | 783 | 788 | 771 | 779 | +0.39% | 90,300 | 206億2471万 | +3.04% |
01/22 | 760 | 777 | 760 | 776 | +2.11% | 78,500 | 205億4528万 | +2.92% |
01/19 | 758 | 778 | 755 | 760 | +1.06% | 93,000 | 201億2166万 | +1.2% |
01/18 | 753 | 766 | 749 | 752 | -0.13% | 83,800 | 199億986万 | +0.4% |
01/17 | 760 | 763 | 750 | 753 | -0.66% | 115,600 | 199億3633万 | +0.67% |
01/16 | 760 | 763 | 756 | 758 | -0.52% | 63,000 | 200億6871万 | +1.61% |
01/15 | 762 | 769 | 754 | 762 | -0.65% | 61,000 | 201億7462万 | +2.28% |
01/12 | 765 | 767 | 754 | 767 | +0.26% | 91,000 | 203億699万 | +3.23% |
01/11 | 777 | 777 | 755 | 765 | -0.65% | 83,900 | 202億5404万 | +3.24% |
01/10 | 769 | 779 | 766 | 770 | 0% | 64,900 | 203億8642万 | +4.34% |
01/09 | 770 | 778 | 757 | 770 | +1.45% | 108,300 | 203億8642万 | +4.62% |
01/05 | 776 | 776 | 753 | 759 | -2.19% | 64,400 | 200億9519万 | +3.55% |
01/04 | 756 | 777 | 743 | 776 | +2.24% | 96,900 | 205億4528万 | +6.16% |
2023 |
12/29 | 758 | 760 | 750 | 759 | -0.39% | 39,800 | 200億9519万 | +4.26% |
12/28 | 758 | 762 | 746 | 762 | +1.33% | 55,000 | 201億7462万 | +4.96% |
12/27 | 740 | 756 | 737 | 752 | +2.59% | 76,600 | 199億986万 | +3.87% |
12/26 | 750 | 755 | 730 | 733 | -1.61% | 56,900 | 194億682万 | +1.52% |
12/25 | 749 | 753 | 737 | 745 | -0.4% | 52,600 | 197億2453万 | +3.47% |
12/22 | 738 | 759 | 738 | 748 | +0.81% | 52,100 | 198億395万 | +4.32% |
12/21 | 748 | 755 | 742 | 742 | -0.93% | 71,400 | 196億4510万 | +3.92% |
12/20 | 750 | 761 | 749 | 749 | +0.4% | 79,400 | 198億3043万 | +5.2% |
12/19 | 743 | 753 | 735 | 746 | +0.81% | 67,900 | 197億5100万 | +5.22% |
12/18 | 742 | 744 | 731 | 740 | -0.54% | 69,300 | 195億9215万 | +4.82% |
12/15 | 733 | 746 | 729 | 744 | +2.62% | 76,600 | 196億9805万 | +5.53% |
12/14 | 735 | 745 | 719 | 725 | -0.14% | 69,400 | 191億9501万 | +3.13% |
12/13 | 712 | 731 | 712 | 726 | +1.97% | 58,400 | 192億2148万 | +3.57% |
12/12 | 728 | 733 | 706 | 712 | -1.39% | 76,500 | 188億5082万 | +1.86% |
12/11 | 712 | 724 | 712 | 722 | +1.98% | 53,300 | 191億1558万 | +3.59% |
12/08 | 714 | 719 | 701 | 708 | -0.84% | 131,500 | 187億4492万 | +2.02% |
12/07 | 726 | 726 | 713 | 714 | -2.46% | 83,700 | 189億377万 | +3.18% |
12/06 | 713 | 738 | 711 | 732 | +3.54% | 96,400 | 193億8034万 | +5.78% |
12/05 | (5%ルール)三井化学(30%) |
12/05 | 715 | 722 | 707 | 707 | -0.98% | 51,200 | 187億1844万 | +2.46% |
12/04 | 706 | 717 | 699 | 714 | +1.71% | 60,200 | 189億377万 | +3.33% |
12/01 | 700 | 709 | 700 | 702 | -0.14% | 60,100 | 185億8606万 | +1.74% |
11/30 | 706 | 707 | 695 | 703 | -0.42% | 91,300 | 186億1254万 | +1.74% |